Genpharmasec Financials

BSE: 531592

₹1.25

₹0.01 (0.81%)

As on 04-Sep-2026IST

Market cap

₹69 Cr

Revenue (TTM)

₹178 Cr

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	177.60	33.72	30.41	25.52	--	--
Total Income	180.44	36.78	31.06	25.62	--	--
Total Expenditure	176.37	33.64	30.36	25.26	--	--
EBITDA	1.24	0.08	0.05	0.26	--	--
Depreciation	2.58	0.81	0.04	0.02	--	--
EBIT	-1.34	-0.73	0.00	0.24	--	--
Interest	1.52	0.45	0.41	0.06	--	--
Other Income	2.84	3.06	0.66	0.10	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.02	1.88	0.25	0.28	--	--
Provision for Tax	0.81	0.65	0.42	-0.84	--	--
Profit after Tax	-0.83	1.23	-0.17	1.12	--	--
Minority Interest	0.71	0.02	0.04	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	-0.12	1.25	-0.13	1.12	--	--

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	66.27	65.16	64.40	15.33	--	--
Minority Interest	0.71	0.12	0.14	--	--	--
Non-Current Liabilities	25.48	4.31	3.46	1.64	--	--
Current Liabilities	47.03	9.84	2.70	2.06	--	--
Total Liabilities	138.15	79.89	71.13	19.88	--	--

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	50.52	52.11	29.73	0.10	--	--
Current Assets	80.52	27.32	40.97	18.93	--	--
Total Assets	138.15	79.89	71.13	19.88	--	--
Total Debt*	--	3.15	3.21	3.08	--	--
Net Current Assets	33.50	17.48	38.27	16.87	--	--
Contingent Liabilities	--	0.02	0.02	0.02	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	2.99	-2.95	-3.06	--	--
Cash Flow from Investing Activities	--	-15.30	-28.06	0.36	--	--
Cash from Financing Activities	--	-1.25	47.85	3.08	--	--
Net Cash Inflow / Outflow	--	-13.56	16.84	0.39	--	--

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	0.00	0.02	0.00	0.02	--	--
Cash EPS (₹)	0.00	0.04	0.00	0.02	--	--
Adjusted Book Value (₹)	1.19	1.18	1.16	0.33	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.05	-0.05	-0.11	--	--
Free Cash Flow per Share (₹)	--	-0.03	-0.07	-0.10	--	--

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	3.43	1.53	1.83	--	--
ROE (%)	-0.18	1.90	-0.42	7.34	--	--
ROA (%)	-0.76	1.64	-0.38	5.91	--	--
EBIT Margin (%)	-0.75	-2.18	0.01	0.93	--	--
Net Margin (%)	-0.46	3.35	-0.55	4.39	--	--
Cash Profit Margin (%)	--	6.06	-0.42	4.49	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	337.77	10.91	19.16	--	--	--
EBIT Growth (%)	-762.58	-19,423.68	-98.40	--	--	--
Net Profit Growth (%)	59.50	827.17	-115.05	--	--	--
EPS Growth (%)	59.22	1,086.96	-109.43	--	--	--
Book Value Growth (%)	--	1.19	320.05	--	--	--

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	-572.08	83.26	--	46.00	--	--
Price / Book Value	1.05	1.61	1.92	5.62	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	22.61	32.66	153.69	244.10	--	--
Close Price (₹)	1.10	1.89	2.23	1.87	--	--
High Price (₹)	2.20	4.32	7.31	4.08	--	--
Low Price (₹)	0.75	1.89	1.61	1.61	--	--
Market Cap (₹ Cr)	69.21	104.65	123.48	86.10	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	0.36	0.05	0.05	0.20	--	--
Short term debt to equity ratio	--	--	--	0.04	--	--
Current Ratio	1.71	2.78	15.16	9.17	--	--
Quick Ratio	1.42	1.94	11.89	4.48	--	--
Interest Coverage	0.99	5.20	1.61	6.03	--	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	16.48	40.32	29.93	22.38	--	--
Asset Turnover	1.63	0.45	0.68	1.34	--	--
Receivable days	--	122.83	88.89	81.67	--	--
Inventory Days	--	92.22	111.15	138.41	--	--
Payable days	--	65.70	28.23	21.37	--	--
Cash Conversion Cycle	--	149.35	171.80	198.70	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.